Marin Veldic

Marin Veldic

orcid

Research Focus & Metrics

Academic Career Length

28Years (1999-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 September 2006 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
RARoberto Carlos Agís-Balboa
Roberto Carlos Agís-Balboa
GPGraziano Pinna
Graziano Pinna
AZAdrian Zhubi
Adrian Zhubi
EMEkrem Maloku
Ekrem Maloku
MVMarin Veldic
Marin Veldic
AGAlessandro Guidotti
Alessandro Guidotti
Allopregnanolone (ALLO) and tetrahydrodeoxycorticosterone (THDOC) are potent positive allosteric modulators of GABA action at GABAAreceptors. ALLO and THDOC are synthesized in the brain from progesterone or deoxycorticosterone, respectively, by the sequential action of two enzymes: 5α-reductase (5α-R) type I and 3α-hydroxysteroid dehydrogenase (3α-HSD). This study evaluates 5α-R type I and 3α-HSD mRNA expression level in mouse brain by usingin situhybridization combined with glutamic acid decarboxylase 67/65, vesicular glutamate transporter 2, glial fibrillary acidic protein, and S100β immunohistochemistry. We demonstrate that 5α-R type I and 3α-HSD colocalize in cortical, hippocampal, and olfactory bulb glutamatergic principal neurons and in some output neurons of the amygdala and thalamus. Neither 5α-R type I nor 3α-HSD mRNAs are expressed in S100β- or glial fibrillary acidic protein-positive glial cells. Using glutamic acid decarboxylase 67/65 antibodies to mark GABAergic neurons, we failed to detect 5α-R type I and 3α-HSD in cortical and hippocampal GABAergic interneurons. However, 5α-R type I and 3α-HSD are significantly expressed in principal GABAergic output neurons, such as striatal medium spiny, reticular thalamic nucleus, and cerebellar Purkinje neurons. A similar distribution and cellular location of neurosteroidogenic enzymes was observed in rat brain. Taken together, these data suggest that ALLO and THDOC, which can be synthesized in principal output neurons, modulate GABA action at GABAAreceptors, either with an autocrine or a paracrine mechanism or by reaching GABAAreceptor intracellular sites through lateral membrane diffusion.

18 December 2003 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
MVMarin Veldic
Marin Veldic
HCH. J. Caruncho
H. J. Caruncho
WLW. S. Liu
W. S. Liu
JDJ. Davis
J. Davis
RSR. Satta
R. Satta
ECE. Costa
E. Costa
A down-regulation of reelin and glutamic acid decarboxylase (GAD) 67 mRNAs was detected in γ-aminobutyric acid (GABA)ergic cortical interneurons of schizophrenia (SZ) postmortem brains ( 10 ), suggesting that the availability of GABA and reelin may be decreased in SZ cortex. In situ hybridization of the mRNA encoding for DNA-methyltransferase 1, which catalyzes the methylation of promoter CpG islands, shows that the expression of this mRNA is increased in cortical GABAergic interneurons but not in pyramidal neurons of SZ brains. Counts of reelin mRNA-positive neurons in Brodmann's area 10 of either nonpsychiatric subjects or SZ patients show that the expression of reelin mRNA is decreased in layer-I, -II, and -IV GABAergic interneurons of SZ patients. These findings are consistent with the hypothesis that the increase of DNA-methyltransferase 1 expression in telencephalic GABAergic interneurons of SZ patients causes a promoter hypermethylation of reelin and GAD 67 and perhaps of other genes expressed in these interneurons. It is difficult to decide whether this dysfunction of GABAergic neurons detected in SZ is responsible for this disease or is a consequence of this disorder. Although at present we cannot differentiate between these two alternatives, it is important to consider that so far a molecular pathology of cortical GABAergic neurons appears to be the most consistent finding associated with SZ morbidity.

28 April 2005 in Psychopharmacology
Verified
Journal Article
Closed access
PDF file
AGAlessandro Guidotti
Alessandro Guidotti
JAJames Auta
James Auta
JDJohn M. Davis
John M. Davis
EDErbo Dong
Erbo Dong
DGDennis R. Grayson
Dennis R. Grayson
ECErminio Costa
Erminio Costa

31 January 2005 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
MVMarin Veldic
Marin Veldic
AGAlessandro Guidotti
Alessandro Guidotti
EMEkrem Maloku
Ekrem Maloku
JDJohn M. Davis
John M. Davis
ECErminio Costa
Erminio Costa
Cortical DNA-methyltransferase 1 (DNMT1) is preferentially expressed in interneurons secreting GABA where it very likely contributes to promoter CpG island hypermethylation, thus causing a down-regulation of promoter functions. To consolidate and expand on previous findings that, in the cortex of schizophrenia (SZ) brains, glutamic acid decarboxylase 67 (GAD 67 ) expression is down-regulated whereas that of DNMT1 is up-regulated, we studied both parameters in Brodmann's area (BA) 9 from the McLean 66 Cohort Collection (Harvard Brain Tissue Resource Center, Belmont, MA). In BA9 of SZ and bipolar disorder patients with psychosis, DNMT1 mRNA and protein expression preferentially increases in layer I, II, and IV interneurons, and this increase is paralleled by a decreased number of GAD 67 mRNA-positive neurons. The increase in DNMT1 and the decrease in GAD 67 -expressing neurons were unrelated to postmortem interval, pH, RNA quality, or to the presence, dose, or duration of antipsychotic (APS) medication, with the exception of a subgroup of SZ patients treated with a combination of valproate and APS in which the expression of DNMT1 failed to change. The DNMT1 increase and the GAD 67 decrease in BA9 interneurons are significant features of SZ and bipolar disorder with psychosis. Interestingly, the DNMT1 increase failed to occur when patients with psychosis received a combination of valproate and APS treatment but not APS monotherapy.

23 January 2006 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
MSM. V. Simonini
M. V. Simonini
LCL. M. Camargo
L. M. Camargo
EDE. Dong
E. Dong
EME. Maloku
E. Maloku
MVMarin Veldic
Marin Veldic
AGA. Guidotti
A. Guidotti
The association of the histone deacetylase (HDAC) inhibitor valproate (VPA) with atypical antipsychotics has become a frequent treatment strategy for schizophrenia and bipolar disorder. Because the VPA doses administered are elevated, one cannot assume that the benefits of the VPA plus antipsychotic treatment are exclusively related to the covalent modifications of nucleosomal histone tails. We compared the actions of N -(2-aminophenyl)-4-[ N -(pyridin-3-yl-methoxycarbonyl)aminomethyl]benzamide derivative (MS-275), which is a potent HDAC inhibitor in vitro , with the actions of VPA for their ability to ( i ) increase the acetylated status of brain nucleosomal histone tail domains and ( ii ) to regulate brain histone- RELN and histone- GAD 67 promoter interactions. MS-275 increases the content of acetylhistone 3 (Ac-H3) in the frontal cortex. Whereas this response peaks after a s.c. injection of 15 μmol/kg, the increase in Ac-H3 content in the hippocampus becomes significant only after an injection of 60 μmol/kg, suggesting that MS-275 is 30- to 100-fold more potent than VPA in increasing Ac-H3 in these brain regions. In contrast to VPA, MS-275, in doses up to 120 μmol/kg, fails to increase Ac-H3 content in the striatum. Chromatin immunoprecipitation shows that MS-275 increases Ac-H3- RELN and Ac-H3- GAD 67 promoter interaction in the frontal cortex. These results suggest that MS-275 is a potent brain region-selective HDAC inhibitor. It is likely that, in addition to MS-275, other benzamide derivatives, such as sulpiride, are brain-region selective inhibitors of HDACs. Hence, some benzamide derivatives may express a greater efficacy than VPA as an adjunctive to antipsychotics in the treatment of epigentically induced psychiatric disorders.

30 January 2007 in Molecular Psychiatry
Verified
Journal Article
Closed access
WRW B Ruzicka
W B Ruzicka
AZA Zhubi
A Zhubi
MVMarin Veldic
Marin Veldic
DGD R Grayson
D R Grayson
ECE Costa
E Costa
AGA Guidotti
A Guidotti